aluates Reports

$ 0.0

Automative

Global Small Nucleic Acid Drug Market Research Report 2026

Published Date: 2026-04-24

Report Code: QYRE-Auto-0G13004

Global Small Nucleic Acid Drug Market Research Report 2022

BUY CHAPTERS

Global Small Nucleic Acid Drug Market Research Report 2026

Code: QYRE-Auto-0G13004

Report

2026-04-24

Pages:115

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Ionis Pharmaceuticals

Sarepta Therapeutics

Biogen

Nippon Shinyaku

Alnylam

SOBI

Novartis

Jazz Pharmaceuticals

Astrazeneca plc

Novo Nordisk

Astellas Pharma

Geron Corporation

Small Nucleic Acid Drug Market Size

The global Small Nucleic Acid Drug market was valued at US$ 7303 million in 2025 and is anticipated to reach US$ 22720 million by 2032, at a CAGR of 17.9% from 2026 to 2032.

Small Nucleic Acid Drug Market

Small nucleic acid drugs, such as siRNA, ASO, miRNA, Aptamer, etc., function based on the RNAi process and offer various advantages, including unlimited target drug ability, high specificity, long half-life, faster and more efficient design, development and production process.

Small nucleic acid drugs, composed of nucleotides, represent a novel class of pharmaceuticals that differ significantly from conventional small molecule and antibody-based therapeutics. These agents function by selectively targeting specific genes or their corresponding messenger RNAs (mRNAs), further modulating gene expression and regulating translation-related processes. Prominent examples within this category include antisense oligonucleotides (ASO), small interfering RNAs (siRNAs), microRNAs (miRNAs), and aptamers. The average gross profit margin of this product is 85%.

The Small Nucleic Acid Drug Market is driven by the transformative potential of small nucleic acids, including microRNA, aptamers, and small interfering RNA (siRNA), in treating a wide spectrum of diseases, from genetic disorders to cancer and viral infections. These therapies harness the power of small nucleic acids to modulate gene expression, inhibit specific targets, and diagnose diseases, offering a precise and personalized approach to treatment. As genomics and RNA-based research advance, and precision medicine gains prominence, the demand for small nucleic acid drugs continues to surge. Innovations in nucleic acid design, delivery systems, and gene-editing technologies further contribute to market expansion. Nevertheless, a significant challenge for this market is the need to overcome hurdles related to safe and efficient drug delivery, minimize off-target effects, ensure long-term safety and efficacy, and navigate complex regulatory pathways. Addressing delivery challenges, optimizing pharmacokinetics, and managing development costs are ongoing hurdles. Additionally, the market faces competition from traditional therapeutic approaches, necessitating continuous research and development efforts to unlock the full therapeutic potential of small nucleic acid drugs. Striking a balance between providing safe, effective, and accessible small nucleic acid therapies while addressing scientific and regulatory challenges is paramount for the continued growth of the Small Nucleic Acid Drug Market.

A key trend in the small nucleic acid drugs market is the development of advanced delivery systems to improve the stability and cellular uptake of these therapies. Lipid nanoparticles (LNPs), polymer-based carriers, and exosome-based delivery platforms are gaining traction due to their ability to protect nucleic acids from degradation and enhance target specificity. These innovations are crucial for overcoming the delivery challenges associated with small nucleic acid drugs, particularly for therapies targeting difficult-to-reach tissues such as the brain or tumors.

While small nucleic acid drugs initially focused on rare genetic disorders, there is a growing trend toward applying these therapies to more common diseases, such as cardiovascular conditions, autoimmune disorders, and metabolic diseases. This shift is driven by advancements in gene-editing tools and RNA interference technology, which expand the potential therapeutic targets. The broadening scope of indications is expected to significantly increase the market size and attract more pharmaceutical companies into this space.

This report delivers a comprehensive overview of the global Small Nucleic Acid Drug market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Small Nucleic Acid Drug. The Small Nucleic Acid Drug market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Small Nucleic Acid Drug market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Small Nucleic Acid Drug manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Small Nucleic Acid Drug Market Report

Report Metric	Details
Report Name	Small Nucleic Acid Drug Market
Accounted market size in 2025	US$ 7303 million
Forecasted market size in 2032	US$ 22720 million
CAGR	17.9%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Antisense Oligonucleotides (ASO) siRNA Other
Segment by Application	Neuromuscular Diseases hATTR Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sarepta Therapeutics, Ionis Pharmaceuticals, Alnylam, Biogen, Nippon Shinyaku, Sobi, Novartis, Jazz Pharmaceuticals, AstraZeneca, Novo Nordisk, Astellas Pharma, Geron Corporation
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Small Nucleic Acid Drug companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Small Nucleic Acid Drug Market growing?

Ans: The Small Nucleic Acid Drug Market witnessing a CAGR of 17.9% during the forecast period 2026-2032.

What is the Small Nucleic Acid Drug Market size in 2032?

Ans: The Small Nucleic Acid Drug Market size in 2032 will be US$ 22720 million.

Who are the main players in the Small Nucleic Acid Drug Market report?

Ans: The main players in the Small Nucleic Acid Drug Market are Sarepta Therapeutics, Ionis Pharmaceuticals, Alnylam, Biogen, Nippon Shinyaku, Sobi, Novartis, Jazz Pharmaceuticals, AstraZeneca, Novo Nordisk, Astellas Pharma, Geron Corporation

What are the Application segmentation covered in the Small Nucleic Acid Drug Market report?

Ans: The Applications covered in the Small Nucleic Acid Drug Market report are Neuromuscular Diseases, hATTR, Other

What are the Type segmentation covered in the Small Nucleic Acid Drug Market report?

Ans: The Types covered in the Small Nucleic Acid Drug Market report are Antisense Oligonucleotides (ASO), siRNA, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Small Nucleic Acid Drug Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Antisense Oligonucleotides (ASO)

1.2.3 siRNA

1.2.4 Other

1.3 Market by Application

1.3.1 Global Small Nucleic Acid Drug Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Neuromuscular Diseases

1.3.3 hATTR

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Small Nucleic Acid Drug Market Perspective (2021–2032)

2.2 Global Small Nucleic Acid Drug Growth Trends by Region

2.2.1 Global Small Nucleic Acid Drug Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Small Nucleic Acid Drug Historic Market Size by Region (2021–2026)

2.2.3 Small Nucleic Acid Drug Forecasted Market Size by Region (2027–2032)

2.3 Small Nucleic Acid Drug Market Dynamics

2.3.1 Small Nucleic Acid Drug Industry Trends

2.3.2 Small Nucleic Acid Drug Market Drivers

2.3.3 Small Nucleic Acid Drug Market Challenges

2.3.4 Small Nucleic Acid Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Small Nucleic Acid Drug Players by Revenue

3.1.1 Global Top Small Nucleic Acid Drug Players by Revenue (2021–2026)

3.1.2 Global Small Nucleic Acid Drug Revenue Market Share by Players (2021–2026)

3.2 Global Top Small Nucleic Acid Drug Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Small Nucleic Acid Drug Revenue

3.4 Global Small Nucleic Acid Drug Market Concentration Ratio

3.4.1 Global Small Nucleic Acid Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Small Nucleic Acid Drug Revenue in 2025

3.5 Global Key Players of Small Nucleic Acid Drug Head Offices and Areas Served

3.6 Global Key Players of Small Nucleic Acid Drug, Products and Applications

3.7 Global Key Players of Small Nucleic Acid Drug, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Small Nucleic Acid Drug Breakdown Data by Type

4.1 Global Small Nucleic Acid Drug Historic Market Size by Type (2021–2026)

4.2 Global Small Nucleic Acid Drug Forecasted Market Size by Type (2027–2032)

5 Small Nucleic Acid Drug Breakdown Data by Application

5.1 Global Small Nucleic Acid Drug Historic Market Size by Application (2021–2026)

5.2 Global Small Nucleic Acid Drug Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Small Nucleic Acid Drug Market Size (2021–2032)

6.2 North America Small Nucleic Acid Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Small Nucleic Acid Drug Market Size by Country (2021–2026)

6.4 North America Small Nucleic Acid Drug Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Small Nucleic Acid Drug Market Size (2021–2032)

7.2 Europe Small Nucleic Acid Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Small Nucleic Acid Drug Market Size by Country (2021–2026)

7.4 Europe Small Nucleic Acid Drug Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Small Nucleic Acid Drug Market Size (2021–2032)

8.2 Asia-Pacific Small Nucleic Acid Drug Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Small Nucleic Acid Drug Market Size by Region (2021–2026)

8.4 Asia-Pacific Small Nucleic Acid Drug Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Small Nucleic Acid Drug Market Size (2021–2032)

9.2 Latin America Small Nucleic Acid Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Small Nucleic Acid Drug Market Size by Country (2021–2026)

9.4 Latin America Small Nucleic Acid Drug Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Small Nucleic Acid Drug Market Size (2021–2032)

10.2 Middle East & Africa Small Nucleic Acid Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Small Nucleic Acid Drug Market Size by Country (2021–2026)

10.4 Middle East & Africa Small Nucleic Acid Drug Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sarepta Therapeutics

11.1.1 Sarepta Therapeutics Company Details

11.1.2 Sarepta Therapeutics Business Overview

11.1.3 Sarepta Therapeutics Small Nucleic Acid Drug Introduction

11.1.4 Sarepta Therapeutics Revenue in Small Nucleic Acid Drug Business (2021–2026)

11.1.5 Sarepta Therapeutics Recent Development

11.2 Ionis Pharmaceuticals

11.2.1 Ionis Pharmaceuticals Company Details

11.2.2 Ionis Pharmaceuticals Business Overview

11.2.3 Ionis Pharmaceuticals Small Nucleic Acid Drug Introduction

11.2.4 Ionis Pharmaceuticals Revenue in Small Nucleic Acid Drug Business (2021–2026)

11.2.5 Ionis Pharmaceuticals Recent Development

11.3 Alnylam

11.3.1 Alnylam Company Details

11.3.2 Alnylam Business Overview

11.3.3 Alnylam Small Nucleic Acid Drug Introduction

11.3.4 Alnylam Revenue in Small Nucleic Acid Drug Business (2021–2026)

11.3.5 Alnylam Recent Development

11.4 Biogen

11.4.1 Biogen Company Details

11.4.2 Biogen Business Overview

11.4.3 Biogen Small Nucleic Acid Drug Introduction

11.4.4 Biogen Revenue in Small Nucleic Acid Drug Business (2021–2026)

11.4.5 Biogen Recent Development

11.5 Nippon Shinyaku

11.5.1 Nippon Shinyaku Company Details

11.5.2 Nippon Shinyaku Business Overview

11.5.3 Nippon Shinyaku Small Nucleic Acid Drug Introduction

11.5.4 Nippon Shinyaku Revenue in Small Nucleic Acid Drug Business (2021–2026)

11.5.5 Nippon Shinyaku Recent Development

11.6 Sobi

11.6.1 Sobi Company Details

11.6.2 Sobi Business Overview

11.6.3 Sobi Small Nucleic Acid Drug Introduction

11.6.4 Sobi Revenue in Small Nucleic Acid Drug Business (2021–2026)

11.6.5 Sobi Recent Development

11.7 Novartis

11.7.1 Novartis Company Details

11.7.2 Novartis Business Overview

11.7.3 Novartis Small Nucleic Acid Drug Introduction

11.7.4 Novartis Revenue in Small Nucleic Acid Drug Business (2021–2026)

11.7.5 Novartis Recent Development

11.8 Jazz Pharmaceuticals

11.8.1 Jazz Pharmaceuticals Company Details

11.8.2 Jazz Pharmaceuticals Business Overview

11.8.3 Jazz Pharmaceuticals Small Nucleic Acid Drug Introduction

11.8.4 Jazz Pharmaceuticals Revenue in Small Nucleic Acid Drug Business (2021–2026)

11.8.5 Jazz Pharmaceuticals Recent Development

11.9 AstraZeneca

11.9.1 AstraZeneca Company Details

11.9.2 AstraZeneca Business Overview

11.9.3 AstraZeneca Small Nucleic Acid Drug Introduction

11.9.4 AstraZeneca Revenue in Small Nucleic Acid Drug Business (2021–2026)

11.9.5 AstraZeneca Recent Development

11.10 Novo Nordisk

11.10.1 Novo Nordisk Company Details

11.10.2 Novo Nordisk Business Overview

11.10.3 Novo Nordisk Small Nucleic Acid Drug Introduction

11.10.4 Novo Nordisk Revenue in Small Nucleic Acid Drug Business (2021–2026)

11.10.5 Novo Nordisk Recent Development

11.11 Astellas Pharma

11.11.1 Astellas Pharma Company Details

11.11.2 Astellas Pharma Business Overview

11.11.3 Astellas Pharma Small Nucleic Acid Drug Introduction

11.11.4 Astellas Pharma Revenue in Small Nucleic Acid Drug Business (2021–2026)

11.11.5 Astellas Pharma Recent Development

11.12 Geron Corporation

11.12.1 Geron Corporation Company Details

11.12.2 Geron Corporation Business Overview

11.12.3 Geron Corporation Small Nucleic Acid Drug Introduction

11.12.4 Geron Corporation Revenue in Small Nucleic Acid Drug Business (2021–2026)

11.12.5 Geron Corporation Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Ionis Pharmaceuticals

Sarepta Therapeutics

Biogen

Nippon Shinyaku

Alnylam

SOBI

Novartis

Jazz Pharmaceuticals

Astrazeneca plc

Novo Nordisk

Astellas Pharma

Geron Corporation

List of Tables

Table 1. Global Small Nucleic Acid Drug Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Antisense Oligonucleotides (ASO)

Table 3. Key Players of siRNA

Table 4. Key Players of Other

Table 5. Global Small Nucleic Acid Drug Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Small Nucleic Acid Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Small Nucleic Acid Drug Market Size by Region (US$ Million), 2021–2026

Table 8. Global Small Nucleic Acid Drug Market Share by Region (2021–2026)

Table 9. Global Small Nucleic Acid Drug Forecasted Market Size by Region (US$ Million), 2027–2032

Table 10. Global Small Nucleic Acid Drug Market Share by Region (2027–2032)

Table 11. Small Nucleic Acid Drug Market Trends

Table 12. Small Nucleic Acid Drug Market Drivers

Table 13. Small Nucleic Acid Drug Market Challenges

Table 14. Small Nucleic Acid Drug Market Restraints

Table 15. Global Small Nucleic Acid Drug Revenue by Players (US$ Million), 2021–2026

Table 16. Global Small Nucleic Acid Drug Market Share by Players (2021–2026)

Table 17. Global Top Small Nucleic Acid Drug Players by Tier (Tier 1, Tier 2, and Tier 3), based on Small Nucleic Acid Drug Revenue, 2025

Table 18. Ranking of Global Top Small Nucleic Acid Drug Companies by Revenue (US$ Million) in 2025

Table 19. Global 5 Largest Players Market Share by Small Nucleic Acid Drug Revenue (CR5 and HHI), 2021–2026

Table 20. Global Key Players of Small Nucleic Acid Drug, Headquarters and Area Served

Table 21. Global Key Players of Small Nucleic Acid Drug, Products and Applications

Table 22. Global Key Players of Small Nucleic Acid Drug, Date of General Availability (GA)

Table 23. Mergers and Acquisitions, Expansion Plans

Table 24. Global Small Nucleic Acid Drug Market Size by Type (US$ Million), 2021–2026

Table 25. Global Small Nucleic Acid Drug Revenue Market Share by Type (2021–2026)

Table 26. Global Small Nucleic Acid Drug Forecasted Market Size by Type (US$ Million), 2027–2032

Table 27. Global Small Nucleic Acid Drug Revenue Market Share by Type (2027–2032)

Table 28. Global Small Nucleic Acid Drug Market Size by Application (US$ Million), 2021–2026

Table 29. Global Small Nucleic Acid Drug Revenue Market Share by Application (2021–2026)

Table 30. Global Small Nucleic Acid Drug Forecasted Market Size by Application (US$ Million), 2027–2032

Table 31. Global Small Nucleic Acid Drug Revenue Market Share by Application (2027–2032)

Table 32. North America Small Nucleic Acid Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 33. North America Small Nucleic Acid Drug Market Size by Country (US$ Million), 2021–2026

Table 34. North America Small Nucleic Acid Drug Market Size by Country (US$ Million), 2027–2032

Table 35. Europe Small Nucleic Acid Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. Europe Small Nucleic Acid Drug Market Size by Country (US$ Million), 2021–2026

Table 37. Europe Small Nucleic Acid Drug Market Size by Country (US$ Million), 2027–2032

Table 38. Asia-Pacific Small Nucleic Acid Drug Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 39. Asia-Pacific Small Nucleic Acid Drug Market Size by Region (US$ Million), 2021–2026

Table 40. Asia-Pacific Small Nucleic Acid Drug Market Size by Region (US$ Million), 2027–2032

Table 41. Latin America Small Nucleic Acid Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. Latin America Small Nucleic Acid Drug Market Size by Country (US$ Million), 2021–2026

Table 43. Latin America Small Nucleic Acid Drug Market Size by Country (US$ Million), 2027–2032

Table 44. Middle East & Africa Small Nucleic Acid Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Middle East & Africa Small Nucleic Acid Drug Market Size by Country (US$ Million), 2021–2026

Table 46. Middle East & Africa Small Nucleic Acid Drug Market Size by Country (US$ Million), 2027–2032

Table 47. Sarepta Therapeutics Company Details

Table 48. Sarepta Therapeutics Business Overview

Table 49. Sarepta Therapeutics Small Nucleic Acid Drug Product

Table 50. Sarepta Therapeutics Revenue in Small Nucleic Acid Drug Business (US$ Million), 2021–2026

Table 51. Sarepta Therapeutics Recent Development

Table 52. Ionis Pharmaceuticals Company Details

Table 53. Ionis Pharmaceuticals Business Overview

Table 54. Ionis Pharmaceuticals Small Nucleic Acid Drug Product

Table 55. Ionis Pharmaceuticals Revenue in Small Nucleic Acid Drug Business (US$ Million), 2021–2026

Table 56. Ionis Pharmaceuticals Recent Development

Table 57. Alnylam Company Details

Table 58. Alnylam Business Overview

Table 59. Alnylam Small Nucleic Acid Drug Product

Table 60. Alnylam Revenue in Small Nucleic Acid Drug Business (US$ Million), 2021–2026

Table 61. Alnylam Recent Development

Table 62. Biogen Company Details

Table 63. Biogen Business Overview

Table 64. Biogen Small Nucleic Acid Drug Product

Table 65. Biogen Revenue in Small Nucleic Acid Drug Business (US$ Million), 2021–2026

Table 66. Biogen Recent Development

Table 67. Nippon Shinyaku Company Details

Table 68. Nippon Shinyaku Business Overview

Table 69. Nippon Shinyaku Small Nucleic Acid Drug Product

Table 70. Nippon Shinyaku Revenue in Small Nucleic Acid Drug Business (US$ Million), 2021–2026

Table 71. Nippon Shinyaku Recent Development

Table 72. Sobi Company Details

Table 73. Sobi Business Overview

Table 74. Sobi Small Nucleic Acid Drug Product

Table 75. Sobi Revenue in Small Nucleic Acid Drug Business (US$ Million), 2021–2026

Table 76. Sobi Recent Development

Table 77. Novartis Company Details

Table 78. Novartis Business Overview

Table 79. Novartis Small Nucleic Acid Drug Product

Table 80. Novartis Revenue in Small Nucleic Acid Drug Business (US$ Million), 2021–2026

Table 81. Novartis Recent Development

Table 82. Jazz Pharmaceuticals Company Details

Table 83. Jazz Pharmaceuticals Business Overview

Table 84. Jazz Pharmaceuticals Small Nucleic Acid Drug Product

Table 85. Jazz Pharmaceuticals Revenue in Small Nucleic Acid Drug Business (US$ Million), 2021–2026

Table 86. Jazz Pharmaceuticals Recent Development

Table 87. AstraZeneca Company Details

Table 88. AstraZeneca Business Overview

Table 89. AstraZeneca Small Nucleic Acid Drug Product

Table 90. AstraZeneca Revenue in Small Nucleic Acid Drug Business (US$ Million), 2021–2026

Table 91. AstraZeneca Recent Development

Table 92. Novo Nordisk Company Details

Table 93. Novo Nordisk Business Overview

Table 94. Novo Nordisk Small Nucleic Acid Drug Product

Table 95. Novo Nordisk Revenue in Small Nucleic Acid Drug Business (US$ Million), 2021–2026

Table 96. Novo Nordisk Recent Development

Table 97. Astellas Pharma Company Details

Table 98. Astellas Pharma Business Overview

Table 99. Astellas Pharma Small Nucleic Acid Drug Product

Table 100. Astellas Pharma Revenue in Small Nucleic Acid Drug Business (US$ Million), 2021–2026

Table 101. Astellas Pharma Recent Development

Table 102. Geron Corporation Company Details

Table 103. Geron Corporation Business Overview

Table 104. Geron Corporation Small Nucleic Acid Drug Product

Table 105. Geron Corporation Revenue in Small Nucleic Acid Drug Business (US$ Million), 2021–2026

Table 106. Geron Corporation Recent Development

Table 107. Research Programs/Design for This Report

Table 108. Key Data Information from Secondary Sources

Table 109. Key Data Information from Primary Sources

Table 110. Authors List of This Report

List of Figures

Figure 1. Small Nucleic Acid Drug Picture

Figure 2. Global Small Nucleic Acid Drug Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Small Nucleic Acid Drug Market Share by Type: 2025 vs 2032

Figure 4. Antisense Oligonucleotides (ASO) Features

Figure 5. siRNA Features

Figure 6. Other Features

Figure 7. Global Small Nucleic Acid Drug Market Size by Application (US$ Million), 2021–2032

Figure 8. Global Small Nucleic Acid Drug Market Share by Application: 2025 vs 2032

Figure 9. Neuromuscular Diseases Case Studies

Figure 10. hATTR Case Studies

Figure 11. Other Case Studies

Figure 12. Small Nucleic Acid Drug Report Years Considered

Figure 13. Global Small Nucleic Acid Drug Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global Small Nucleic Acid Drug Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Small Nucleic Acid Drug Market Share by Region: 2025 vs 2032

Figure 16. Global Small Nucleic Acid Drug Market Share by Players in 2025

Figure 17. Global Small Nucleic Acid Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Small Nucleic Acid Drug Revenue in 2025

Figure 19. North America Small Nucleic Acid Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America Small Nucleic Acid Drug Market Share by Country (2021–2032)

Figure 21. United States Small Nucleic Acid Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada Small Nucleic Acid Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Small Nucleic Acid Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Small Nucleic Acid Drug Market Share by Country (2021–2032)

Figure 25. Germany Small Nucleic Acid Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France Small Nucleic Acid Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. Small Nucleic Acid Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy Small Nucleic Acid Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia Small Nucleic Acid Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland Small Nucleic Acid Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Small Nucleic Acid Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Small Nucleic Acid Drug Market Share by Region (2021–2032)

Figure 33. China Small Nucleic Acid Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan Small Nucleic Acid Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea Small Nucleic Acid Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia Small Nucleic Acid Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India Small Nucleic Acid Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand Small Nucleic Acid Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Small Nucleic Acid Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Small Nucleic Acid Drug Market Share by Country (2021–2032)

Figure 41. Mexico Small Nucleic Acid Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil Small Nucleic Acid Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Small Nucleic Acid Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Small Nucleic Acid Drug Market Share by Country (2021–2032)

Figure 45. Israel Small Nucleic Acid Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia Small Nucleic Acid Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE Small Nucleic Acid Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Sarepta Therapeutics Revenue Growth Rate in Small Nucleic Acid Drug Business (2021–2026)

Figure 49. Ionis Pharmaceuticals Revenue Growth Rate in Small Nucleic Acid Drug Business (2021–2026)

Figure 50. Alnylam Revenue Growth Rate in Small Nucleic Acid Drug Business (2021–2026)

Figure 51. Biogen Revenue Growth Rate in Small Nucleic Acid Drug Business (2021–2026)

Figure 52. Nippon Shinyaku Revenue Growth Rate in Small Nucleic Acid Drug Business (2021–2026)

Figure 53. Sobi Revenue Growth Rate in Small Nucleic Acid Drug Business (2021–2026)

Figure 54. Novartis Revenue Growth Rate in Small Nucleic Acid Drug Business (2021–2026)

Figure 55. Jazz Pharmaceuticals Revenue Growth Rate in Small Nucleic Acid Drug Business (2021–2026)

Figure 56. AstraZeneca Revenue Growth Rate in Small Nucleic Acid Drug Business (2021–2026)

Figure 57. Novo Nordisk Revenue Growth Rate in Small Nucleic Acid Drug Business (2021–2026)

Figure 58. Astellas Pharma Revenue Growth Rate in Small Nucleic Acid Drug Business (2021–2026)

Figure 59. Geron Corporation Revenue Growth Rate in Small Nucleic Acid Drug Business (2021–2026)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Nucleic Acid Medicine Market Research Report 2025

Global Small Interfering RNA siRNA Drugs Market Research Report 2024

Global Small Interfering RNA siRNA based Therapeutics Market Research Report 2024

Global RNA Interference RNAi Based Therapeutics Market Research Report 2024

Global RNA based Therapeutics Drug Market Research Report 2024

Global Nucleic acid based Therapeutics Drug Market Research Report 2024

Global Nucleic Acid Therapeutic Market Research Report 2024

Global Nucleic Acid based Therapy Market Research Report 2024

Global Low Molecular Weight Nucleic Acid Drugs Market Research Report 2025

Global Small Nucleic Acid Based Drug Market Research Report 2025

Global Antisense oligonucleotides ASO Drug and siRNA Drug Market Research Report 2024

Antisense and RNAi Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oligonucleotide Drugs ONs Market Research Report 2025

Global Nucleic Acid Aptamers Market Research Report 2025

Global ASO based Drug Market Research Report 2024

Small Molecule Nucleic Acid Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global miRNA Drug Market Research Report 2024

Global Antisense Oligonucleotides ASO Drug Market Research Report 2024

Global Antisense Oligonucleotides ASO Therapy Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions